Burnout and Resilience in Community Pharmacists in Qatar during the COVID-19 Pandemic: a Cross Sectional Study

Objective: The main aim of this study is to illustrate the prevalence of burnout and resilience among community pharmacists in Qatar during the COVID-19 pandemic. Methods: This is a cross-sectional study design that included the collection and analysis of quantitative data from community pharmacists in Qatar using a cross-sectional survey. Results: Overall, participants had a moderate level of burnout as illustrated in the mean scores of the three dimensions; 22.11±13.053 for emotional exhaustion, 7.17±6.55 for depersonalization, and 35.94±11.47 for personal accomplishment. The findings demonstrated that 15.2%, 15.6%, and 5.4% of community pharmacists had moderate levels of depression, anxiety, and stress, respectively. Further, they showed high resilience (35.7±8.57). Mental health outcomes were statistically positively correlated with fear while age was negatively correlated with depersonalization. Conclusion: This study is the first study to report the prevalence of mental health outcomes among community pharmacists during COVID-19 in Qatar. The pharmacists experienced moderate burnout but high resilience which indicates their high potential to overcome difficulties. Future interventions at the personal, national and organizational levels are needed to improve mental health during this pandemic by preventing and managing stress, improving self-efficacy and resilience, and providing adequate social support

Mental health, burnout and resilience in community pharmacists during the COVID-19 pandemic: A cross-sectional study

BackgroundThe study aimed to assess burnout, resilience, and levels of depression, anxiety, stress and fear among community pharmacists during the pandemic, and examine if fear of COVID-19 is associated with these outcomes of interest. MethodsA cross-sectional survey of community pharmacists in Qatar was conducted. Pharmacists’ burnout was measured by the Maslach Burnout Inventory: Human Services Survey for Medical Personnel (MBI-HSS™ for MP-Mindgarden). Resilience was assessed using the Connor-Davidson Resilience Scale-10 (CD-RISC-10). Depression, anxiety, and stress were measured by the Depression, Anxiety, and Stress Scale (DASS-21). Fear of COVID-19 was assessed by the Fear of COVID-19 Scale (FCV-19S). Results256 respondents completed the survey and were included in the final study analysis (response rate: 42.7%). Overall, participants reported a moderate level of burnout as illustrated in the mean scores of the three burnout dimensions; 20.54 (SD = 12.37) for emotional exhaustion, 6.76 (SD = 6.22) for depersonalization, and 36.57 (SD = 9.95) for personal accomplishment. Moreover, depression, anxiety and stress were reported by 44.8%, 53.2% and 25.4% of particiants respectively. Participants had shown moderate resilience (mean score: 27.64 (SD = 8.31)) and their mean score fear of COVID19 was 15.67 (SD = 6.54). Fear of COVID-19 was a statistically significant and an independent predictor of depression, anxiety, and stress levels. ConclusionsThe pharmacists experienced moderate burnout but moderate resilience, which indicates their potential to overcome difficulties. Future interventions at the personal, national and organizational levels are required to enhance the pharmacists’ wellbeing by decreasing stress, improving self-efficacy and resilience, and preventing burnout.This study was funded by student grants [QUST-2-CPH-2020-21] from the Qatar University Office of Research and Graduate Studies. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of Qatar University

Mental health, burnout and resilience in community pharmacists during the COVID-19 pandemic: A cross-sectional study

Background: The study aimed to assess burnout, resilience, and levels of depression, anxiety, stress and fear among community pharmacists during the pandemic, and examine if fear of COVID-19 is associated with these outcomes of interest. Methods: A cross-sectional survey of community pharmacists in Qatar was conducted. Pharmacists’ burnout was measured by the Maslach Burnout Inventory: Human Services Survey for Medical Personnel (MBI-HSS™ for MP-Mindgarden). Resilience was assessed using the Connor-Davidson Resilience Scale-10 (CD-RISC-10). Depression, anxiety, and stress were measured by the Depression, Anxiety, and Stress Scale (DASS-21). Fear of COVID-19 was assessed by the Fear of COVID-19 Scale (FCV-19S). Results: 256 respondents completed the survey and were included in the final study analysis (response rate: 42.7%). Overall, participants reported a moderate level of burnout as illustrated in the mean scores of the three burnout dimensions; 20.54 (SD = 12.37) for emotional exhaustion, 6.76 (SD = 6.22) for depersonalization, and 36.57 (SD = 9.95) for personal accomplishment. Moreover, depression, anxiety and stress were reported by 44.8%, 53.2% and 25.4% of particiants respectively. Participants had shown moderate resilience (mean score: 27.64 (SD = 8.31)) and their mean score fear of COVID19 was 15.67 (SD = 6.54). Fear of COVID-19 was a statistically significant and an independent predictor of depression, anxiety, and stress levels. Conclusions: The pharmacists experienced moderate burnout but moderate resilience, which indicates their potential to overcome difficulties. Future interventions at the personal, national and organizational levels are required to enhance the pharmacists’ wellbeing by decreasing stress, improving self-efficacy and resilience, and preventing burnout